Novel glitazones: Design, synthesis, glucose uptake and structure-activity relationships

被引：42
作者：
Kumar, B. R. Prashantha [2 ]
Nanjan, M. J. [1 ]
机构：
[1] JSS Coll Pharm, TIFAC CORE, Ootacamund 643001, Tamil Nadu, India
[2] JSS Coll Pharm, Dept Pharmaceut Chem, Ootacamund 643001, Tamil Nadu, India
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 06期
关键词：
Glitazones; Glucose uptake; Diabetes; PPAR-gamma; Antidiabetic activity; PROLIFERATOR-ACTIVATED RECEPTORS; LIGANDS; AGENTS;
D O I：
10.1016/j.bmcl.2010.01.125
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Glitazones are known to exhibit antihyperglycemic activity by decreasing peripheral insulin resistance. In the present study, we have designed some novel glitazones based on the structure-activity relationships as possible PPAR-gamma agonists. The manually designed glitazones were synthesized by using the appropriate synthetic schemes and screened for their in vitro antihyperglycemic activity by estimating glucose uptake by rat hemi-diaphragm, both in the absence and in the presence of external insulin. Some of the glitazones exhibited good antihyperglycemic activity in presence of insulin. Illustration about their design, synthesis, evaluation, and structure-activity relationships is described. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码：1953 / 1956
页数：4
相关论文
共 26 条
  • [1] Aleglitazar, a new, potent, and balanced dual PPARα/γ agonist for the treatment of type II diabetes
    Benardeau, Agnes
    Benz, Joerg
    Binggeli, Alfred
    Blum, Denise
    Boehringer, Markus
    Grether, Uwe
    Hilpert, Hans
    Kuhn, Bernd
    Maerki, Hans Peter
    Meyer, Markus
    Puentener, Kurt
    Raab, Susanne
    Ruf, Armin
    Schlatter, Daniel
    Mohr, Peter
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (09) : 2468 - 2473
  • [2] Chattopadhyay R R, 1992, Indian J Physiol Pharmacol, V36, P137
  • [3] From molecular action to physiological outputs: Peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions
    Feige, JN
    Gelman, L
    Michalik, L
    Desvergne, B
    Wahli, W
    [J]. PROGRESS IN LIPID RESEARCH, 2006, 45 (02) : 120 - 159
  • [4] HELEN DB, 2007, DIABETES RES CLIN PR, V76, P279
  • [5] Janine C, 1999, BIOORG MED CHEM LETT, V9, P3439, DOI [10.1016/S0960-894X(99)00630-7, DOI 10.1016/S0960-894X(99)00630-7]
  • [6] Structure-based design of indole propionic acids as novel PPARα/γ co-agonists
    Kuhn, Bernd
    Hilpert, Hans
    Benz, Joerg
    Binggeli, Alfred
    Grether, Uwe
    Humm, Roland
    Maerki, Hans Peter
    Meyer, Markus
    Mohr, Peter
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (15) : 4016 - 4020
  • [7] Kumar BRP, 2008, LETT DRUG DES DISCOV, V5, P79
  • [8] Kumar BRP, 2007, INDIAN J PHARMACOL, V39, P299
  • [9] Microwave induced synthesis of the thiazolidine-2,4-dione motif and the efficient solvent free-solid phase parallel syntheses of 5-benzylidene-thiazolidine-2,4-dione and 5-benzylidene-2-thioxo-thiazolidine-4-one compounds
    Kumar, B. R. Prashantha
    Karvekar, M. D.
    Adhikary, L.
    Nanjan, M. J.
    Suresh, B.
    [J]. JOURNAL OF HETEROCYCLIC CHEMISTRY, 2006, 43 (04) : 897 - 903
  • [10] Comparative molecular similarity indices analysis for predicting the antihyperglycemic activity of thioglitazones
    Kumar, B. R. Prashantha
    Nanjan, M. J.
    [J]. MEDICINAL CHEMISTRY RESEARCH, 2010, 19 (08) : 1000 - 1010
123